Results 191 to 200 of about 57,892 (307)
Abstract Background Calcitonin gene‐related peptide (CGRP) is a key mediator in migraine pathophysiology, and the development of gepants, novel CGRP receptor antagonists, has expanded therapeutic options for both acute and preventive treatment. This scoping review aims to synthesize current evidence on the pharmacology, clinical applications, safety ...
Luigi Francesco Iannone +5 more
wiley +1 more source
Cervical musculoskeletal function is variable in tension‐type headache: A cluster analysis
Abstract Objectives This study was conducted to (1) consider the causes of neck pain in tension‐type headache (TTH) by investigating how the patients with TTH, idiopathic neck pain (INP), and healthy controls group together based on the presence of cervical musculoskeletal dysfunction; and (2) determine any differences in TTH features, pain sensitivity,
Chalomjai Pensri +5 more
wiley +1 more source
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial. [PDF]
Jensen RH +13 more
europepmc +1 more source
Abstract Objective To develop a comprehensive, evidence‐based, patient‐centered conceptual model of migraine and to derive a measurement framework for the development or selection of clinical outcome assessments used in clinical trials of treatments for migraine.
Rikki Mangrum +6 more
wiley +1 more source
Comparison of brain volumes in episodic and chronic migraine using automated whole-brain volumetry. [PDF]
Akçay Hİ.
europepmc +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katharina A. Kälber +3 more
wiley +1 more source
xxxx Abstract Objective To evaluate the effects of a short, structured multimodal day‐clinic program on health‐related quality of life and disability in patients with primary headache disorders. Background Although monoclonal antibodies targeting the calcitonin gene‐related peptide (CGRP) pathway have substantially advanced migraine prophylaxis, a ...
Nadja Fiebig +7 more
wiley +1 more source
Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA Administration. [PDF]
Gine-Cipres E +6 more
europepmc +1 more source
Suzetrigine as a novel treatment for headache disorders: A case series
Abstract Suzetrigine is a selective voltage‐gated sodium channel blocker that was recently approved by the US Food and Drug Administration for the treatment of acute pain. We retrospectively evaluated the efficacy and tolerability of suzetrigine for the treatment of different headache disorders in patients refractory to standard treatments in an ...
Molly Fensterwald +15 more
wiley +1 more source
Using Multi-Informant Qualitative Data to Inform Adaptations to Mindfulness-Based Interventions for Adolescents With Chronic Migraine. [PDF]
Clementi MA +5 more
europepmc +1 more source

